Search
Descriptor English: Prazosin
Descriptor Spanish: Prazosina
Descriptor prazosina
Entry term(s) furazosina
Scope note: Antagonista selectivo alfa-1 adrenérgico utilizado en el tratamiento de la insuficiencia cardíaca, hipertensión, feocromocitoma. síndrome de Raynaud, hipertrofia prostática y retención urinaria.
Descriptor Portuguese: Prazosina
Descriptor French: Prazosine
Entry term(s): Furazosin
HCL, Prazosin
Hydrochloride, Prazosin
Minipress
Pratsiol
Prazosin HCL
Prazosin Hydrochloride
Tree number(s): D03.633.100.786.750
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D011224
Scope note: A selective adrenergic alpha-1 antagonist used in the treatment of HEART FAILURE; HYPERTENSION; PHEOCHROMOCYTOMA; RAYNAUD DISEASE; PROSTATIC HYPERTROPHY; and URINARY RETENTION.
Allowable Qualifiers: AA analogs & derivatives
AD administration & dosage
AE adverse effects
AG agonists
AI antagonists & inhibitors
AN analysis
BL blood
CF cerebrospinal fluid
CH chemistry
CL classification
CS chemical synthesis
EC economics
HI history
IM immunology
IP isolation & purification
ME metabolism
PD pharmacology
PK pharmacokinetics
PO poisoning
RE radiation effects
SD supply & distribution
ST standards
TO toxicity
TU therapeutic use
UR urine
Pharm Action: Antihypertensive Agents
Adrenergic alpha-1 Receptor Antagonists
Registry Number: XM03YJ541D
CAS Type 1 Name: Piperazine, 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonyl)-
Previous Indexing: Piperazines (1974-1976)
Quinazolines (1974-1976)
Public MeSH Note: 86; was see under QUINAZOLINES 1977-85
History Note: 86(77); was see under QUINAZOLINES 1977-85
DeCS ID: 22618
Unique ID: D011224
NLM Classification: QV 151
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 1986/01/01
Date of Entry: 1976/04/13
Revision Date: 2017/05/24
Prazosin - Preferred
Concept UI M0017441
Scope note A selective adrenergic alpha-1 antagonist used in the treatment of HEART FAILURE; HYPERTENSION; PHEOCHROMOCYTOMA; RAYNAUD DISEASE; PROSTATIC HYPERTROPHY; and URINARY RETENTION.
Preferred term Prazosin
Entry term(s) Furazosin
Prazosin Hydrochloride - Narrower
Concept UI M0544014
Preferred term Prazosin Hydrochloride
Entry term(s) HCL, Prazosin
Hydrochloride, Prazosin
Prazosin HCL
Minipress - Narrower
Concept UI M0017442
Preferred term Minipress
Pratsiol - Narrower
Concept UI M0017440
Preferred term Pratsiol



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.

Go to survey